Stock Taper
HeartBeam, Inc. develops portable cardiovascular diagnostic devices that transmit ECG data from patients to physicians via smartphones and cloud-based systems, enabling remote cardiac assessment.

HeartBeam's portable, FDA-cleared system records 3D ECGs at home, including 12-lead synthesis software, enabling hospital-grade cardiac monitoring outside clinical settings, with a limited launch planned for Q1 2026.
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
OKUR | $2.95 | COMPARE |
XLO | $9.13 | COMPARE |
PDSB | $0.81 | COMPARE |
ALGS | $5.24 | COMPARE |
RNTX | $0.80 | COMPARE |
TPST | $0.97 | COMPARE |